Search Reset All Therapy AreasChronic Kidney DiseaseOncology All ProductsBiosimilars All GeographyArgentinaAsia PacificBrazilChileChinaColombiaEuropeFranceGeographyGermanyItalyLatin AmericaMexicoMiddle East / AfricaSouth KoreaTaiwanUS All Years202220192018201720162015 March 2, 2022 Biosimilars | Emerging Biosimilars | Oncology | Trastuzumab | Germany | Wave 2 | 2019 December 30, 2019 Biosimilars | Emerging Biosimilars | Immunology | Adalimumab | Germany | Wave 3 | 2019 July 11, 2019 Biosimilars | Emerging Biosimilars | Oncology | Trastuzumab | Germany | Wave 3 | 2019 June 25, 2019 Biosimilars | Emerging Biosimilars | Immunology | Adalimumab | Germany | Wave 2 | 2019 February 14, 2019 Biosimilars | Emerging Biosimilars | Immunology | Adalimumab | Germany | Wave 1 | 2019 August 8, 2018 Biosimilars | Emerging Biosimilars | Truxima/Rixathon Launch Tracker | Germany | Wave 3 | 2018 August 7, 2018 Biosimilars | Emerging Biosimilars | Oncology | Herzuma | Germany | Wave 1 | 2018 February 13, 2018 Biosimilars | Emerging Biosimilars | Truxima/Rixathon Launch Tracker | Germany | Wave 2 | 2018 August 25, 2017 Biosimilars | Emerging Biosimilars | Truxima Launch Tracker | Germany | Wave 1 | 2017 August 4, 2016 Immunology | Inflectra/Remsima Launch Tracking (Germany) | Wave 3 | 2016 January 22, 2016 Emerging Biosimilars | Immunology | Inflectra/Remsima Wave 2 | Germany | 2016 October 20, 2015 Nephrology in Chronic Kidney Disease Non-Dialysis | Chart Trends | France, Germany, and Italy | 2015 September 1, 2015 Emerging Biosimilars | Immunology | Inflectra/Remsima Wave 1 | Germany | 2015 August 12, 2015 Biosimilars Advisory Service : Acceptance of Biosimilars Across Physician Specialties | US,France and Germany | 2015